Abstract
Granular shape biphasic calcium phosphate (BCP) bone grafts with and without doping of silicon cations were evaluated in regards to biocompatibility and MG-63 cellular response. To do this we studied Cellular cytotoxicity, cellular adhesion and spreading behavior and cellular differentiation with alizarin red S staining. Gene expression in MG-63 cells on the implanted bone substitutes was also examined at different time points using RT-PCR. In comparison, the Si-doped BCP granule showed more cellular viability than the BCP granule without doping in MTT assay. Moreover, cell proliferation was much higher when Si doping was employed. The cells grown on the silicon-doped BCP substitutes had more active filopodial growth with cytoplasmic webbing that proceeded to the flattening stage, which was indicative of well cellular adhesion. When these cells were exposed to Si-doped BCP granules for 14 days, well differentiated MG-63 cells were observed. Osteonectin and osteopontin genes were highly expressed in the late stage of differentiation (14 days), whereas collagen type I mRNA were found to be highly expressed during the early stage (day 3). These combined results of this study demonstrate that silicon-doped BCP enhanced osteoblast attachment/spreading, proliferation, differentiation and gene expression.
Similar content being viewed by others
References
Hench LL. Biomaterials: a forecast for the future. Biomaterials. 1998;19:1419–23.
Oonishi H. Orthopaedic applications of hydroxyapatite. Biomaterials. 1991;12:171–8.
Yang S, Leong K-F, Du Z, Chua C-K. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 2001;7:679–89.
Chu T-MG, Orton DG, Hollister SJ, Feinberg SE, Halloran JW. Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures. Biomaterials. 2002;23:1283–93.
Mastrogiacoma M, Muraglia A, Komlev V, Peryin F, Rustichelli F, Crovace A, et al. Tissue engineering of bone: search for a better scaffold. Orthodont Craniofac Res. 2005;8:277–84.
Dorozhkin SV, Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed. 2002;41:3130–46.
Buma P, Van Loon PJM, Versleyen H, Weinans H, Slooff TJJH, De Groot K, et al. Histological and biomechanical analysis of bone and interface reactions around hydroxyapatite-coated intramedullary implants of different stiffness: a pilot study on the goat. Biomaterials. 1997;18:1251–60.
Van Landuyt P, Li F, Keustermans JP, Streydio JM, Delannay F, Munting E. The influence of high sintering temperatures on the mechanical properties of hydroxylapatite. J Mater Sci: Mater Med. 1995;6:8–13.
Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials. 1996;17:31–5.
Gauthier O, Goyenvalle E, Bouler JM, Guicheus J, Pilet P, Weiss P, et al. Macroporous biphasic calcium phosphate ceramics versus injectable bone substitute: a comparative study 3 and 8 weeks after implantation in rabbit bone. J Mater Sci: Mater Med. 2001;12:385–90.
Yuan H, Yang Z, Bruijn JD, Groot K, Zhang X. Material-dependent bone induction by calcium phosphate ceramics: a 2.5-year study in dog. Biomaterials. 2001;22:2617–23.
Piattelli A, Scarano A, Mangano C. Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement. Biomaterials. 1996;17:1767–70.
Daculsi G. Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomaterials. 1998;19:1473–8.
Elliot J. Structure and chemistry of the apatites and other calcium orthophosphates. New York: Elsevier; 1994.
Gibson IR, Best SM, Bonfield W. Chemical characterization of silicon-substituted hydroxyapatite. J Biomed Mater Res. 1999;44:422–8.
Carlisle EM. Silicon: a possible factor in bone calcification. Science. 1970;167:279–80.
Carlisle EM. A silicon requirement for normal skull formation in chicks. J Nutr. 1980;110(2):352–9.
Carlisle EM. Biochemical and morphological changes associated with long bone abnormalities in silicon deficiency. J Nutr. 1980;110:1046–56.
Alexandra EP. Nanoscale characterization of the interface between bone and hydroxyapatite implants and the effect of silicon on bone apposition. Micron. 2006;37:681–8.
Gao T, Aro HT, Ylänen H, Vuorio E. Silica-based bioactive glasses modulate expression of bone morphogenetic protein-2 mRNA in Saos-2 osteoblasts in vitro. Biomaterials. 2001;22:1475–83.
Reffitt DM, Ogston N, Jugdoahsingh R, Cheung HFJ, Evans BAJ, Thompson RPH, et al. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone. 2003;32:127–35.
Arumugam MQ, Ireland DC, Brooks RA, Rushton N, Bonfield W. Orthosilicic acid increases collagen type I mRNA expression in human bone-derived osteoblasts in vitro. Key Eng Mater. 2004;254:869–72.
Ni S, Chang J, Chou L, Zhai W. Comparison of osteoblast-like cell responses to calcium silicate and tricalcium phosphate ceramics in vitro. J Biomed Mater Res. 2006;80B:174–83.
Patel N, Best SM, Bonfield W. A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. J Biomed Mater Res. 2002;69:1199–206.
Patel N, Brooks RA, Clarke MT, Lee PMT, Rushton N, Gibson IR, et al. In vivo assessment of hydroxyapatite and silicate-substituted hydroxyapatite granules using an ovine defect model. J Biomed Mater Res. 2005;16:429–40.
Hing KA, Revell PA, Smith N, Buckland T. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials. 2006;27:5014–26.
Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Comparison of in vivo dissolution processes in hydroxyapatite and silicon substituted hydroxyapatite bioceramics. Biomaterials. 2003;24:4609–20.
Botelho CM, Lopes MA, Gibson IR, Best SM, Santos JD. Structural analysis of Si-substituted hydroxyapatite: zeta potential and X-ray photoelectron spectroscopy. J Mater Sci: Mater Med. 2002;13:1123–7.
Balas F, Perez-Pariente J, Vallet-Regi M. In vivo bioactivity of silicon substituted hydroxyapatites. J Biomed Mater Res. 2003;66A:364–75.
Popovic’ D, Halloran JW, Hilmas GE, Brady GA, Somas S, Barda A, Zywicki G, Process for preparing textured ceramic composites, U.S. Patent 5645781.1997.
Baskaran S, Nunn S, Popovic’ D, Halloran JW. Fibrous monolithic ceramics: I, fabrication, microstructure and indentation behavior. J Am Ceram Soc. 1993;76:2209–16.
Lee B-T, Sarkar SK, Song H-Y. Microstructure and material properties of double-network type fibrous (Al2O3–m-ZrO2)/t-ZrO2 composites. J Eur Ceram Soc. 2008;28:229–33.
Mickisch G, Fajta S, Keilhauer G, Schlick E, Tschada R, Alken P. Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT). Urol Res. 1990;18:131–6.
International standard 1999. Biological evaluation of medical devices. Part 5: Test for in vitro cytotoxicity. ISO-10993-5;1999 (E).
Patel N, Brooks RA, Clarke MT, Lee PMT, Rushton N, Gibson IR, et al. In vivo assessment of hydroxyapatite and silicate-substituted granules using an ovine model. J Mater Sci: Mater Med. 2005;16:429–40.
Hott M, Noel B, Bernache-Assolant D, Rey C, Marie PJ. Proliferation and differentiation of human trabecular osteoblastic cells on hydroxyapatite. J Biomed Mater Res. 1997;37:508–16.
Pioletti DP, Muller J, Rakotomanana LR. Effect of micromechanical stimulations on osteoblasts: development of a device simulating the mechanical situation at the bone-implant interface. Biomechanics. 2003;36:131–5.
Nanci A, Wuest JD, Peru L, Brunet P, Sharma V, Zalzal S, et al. Chemical modification of titanium surfaces for covalent attachment of biological molecules. J Biomed Mater Res. 1998;40:324–35.
Webb K, Hlady V, Tresco PA. Relationships among cell attachment, spreading, cytoskeletal organization, and migration rate for anchorage-dependent cells on model surfaces. J Biomed Mater Res. 2000;49:362–8.
Bigerelle M, Anselme K, Dufresne E. An unscaled parameter to measure the order of surfaces: a new surface elaboration to increase cells adhesion. Biomol Eng. 2002;19:79–83.
Xu L, Khor KA. Chemical analysis of silica doped hydroxyapatite biomaterials consolidated by a spark plasma sintering method. J Inorg Biochem. 2007;101:187–95.
Rajaraman R, Rounds DE, Yen SPS, Rembaum A. A scanning electron microscope study of cell adhesion and spreading in vitro. Exp Cell Res. 1974;88:327–39.
Grinnell F, Milam M, Srere PA. Studies on cell adhesion. III. Adhesion of baby hamster kidney cells. J Cell Biol. 1973;56:659.
Taylor AC. Attachment and spreading of cells in culture. Exp Cell Res. 1961;8:154–73.
Lajeunesse D, Frondoza C, Schoffield B, Sacktor B. Osteocalcin secretion by the human osteosarcoma cell line MG63. J Bone Miner Res. 1990;5:915–22.
Kartsogiannis V, Ng KW. Cell lines and primary cell cultures in the study of bone cell biology. Mol Cell Endocrinol. 2004;228:79–102.
Thian ES, Huang J, Best SM, Barber ZH, Bonefield W. Magnetron co-sputtered silicon-containing hydroxyapatite thin films—an in vitro study. Biomaterials. 2005;26(16):2947–56.
Bohner M. Silicon-substituted calcium phosphates—a critical view. Biomaterials. 2009;30:6403–6.
Deluca PP, Schrier JA. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems. Pharm Dev Technol. 1999;4:611–21.
De la Piedra GC, Jiménez RT. Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget’s bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers. An Med Intern. 1990;7:534–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Byun, IS., Sarkar, S.K., Anirban Jyoti, M. et al. Initial biocompatibility and enhanced osteoblast response of Si doping in a porous BCP bone graft substitute. J Mater Sci: Mater Med 21, 1937–1947 (2010). https://doi.org/10.1007/s10856-010-4061-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-010-4061-1